| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783966 For diagnosis and treatment of diseases; for production of glycolipids |
| 08/31/2004 | US6783964 Microencapsulated pancreatic islet cells |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783953 For prevention and treatment of angiogenesis |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783943 Rolling circle amplification detection of RNA and DNA |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | US6783756 Methods for regulating gene expression |
| 08/31/2004 | CA2061362C Method for producing human nerve growth factor-2 |
| 08/26/2004 | WO2004072306A1 Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents |
| 08/26/2004 | WO2004072305A2 Atlastin |
| 08/26/2004 | WO2004072273A1 Progenitor cells from wharton's jelly of human umbilical cord |
| 08/26/2004 | WO2004072264A2 Fate determination by hes 1 in hematopoietic stem-progenitor cells and uses thereof |
| 08/26/2004 | WO2004072262A2 Cultured cd14+ antigen presenting cells |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072251A2 Directed genetic modifications of human stem cells |
| 08/26/2004 | WO2004072226A2 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| 08/26/2004 | WO2004072220A2 Process of sex selection of mammal spermatozoa and method to control quality of frozen sexed semen doses |
| 08/26/2004 | WO2004072117A2 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | WO2004072105A2 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 08/26/2004 | WO2004072104A2 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004071546A1 Method of producing a collagen layer |
| 08/26/2004 | WO2004071545A2 Compositions for neuronal tissue regeneration |
| 08/26/2004 | WO2004071517A2 Uses of il-23 related reagents |
| 08/26/2004 | WO2004071462A2 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 08/26/2004 | WO2004071443A2 Methods and compositions for modulating stem cells |
| 08/26/2004 | WO2004071407A2 Antisense modulation of ptp1b expression |
| 08/26/2004 | WO2004071283A2 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 08/26/2004 | WO2004071176A1 Method of manufacturing a growth substrate |
| 08/26/2004 | WO2004058980A3 Plants having modified growth characteristics and a method for making the same |
| 08/26/2004 | WO2004057002A3 Production of heterologous glycosylated proteins in bryophyte cells |
| 08/26/2004 | WO2004053069A3 PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS |
| 08/26/2004 | WO2004050897A3 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 08/26/2004 | WO2004046318A3 Improved clonal cell lines derived from bti-tn-5b1-4 |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004044145A3 Compositions and methods for enhancing disease resistance in fish |
| 08/26/2004 | WO2004038004A3 Fibrin-based tissue-engineered vasculature |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004035609A3 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 08/26/2004 | WO2004015066A3 Sperm-specific cation channel, catsper-4, and uses therefor |
| 08/26/2004 | WO2004011622A3 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
| 08/26/2004 | WO2004002431A3 Humanized anti-lymphotoyin beta receptor antibodies |
| 08/26/2004 | WO2003094965A8 Modulation of neural stem cells with s1p or lpa receptor agonists |
| 08/26/2004 | WO2003093411A3 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 08/26/2004 | WO2003091447A3 D1-1 nucleic acids, polypeptides and related methods |
| 08/26/2004 | WO2003091405A3 In vitro ischemia model |
| 08/26/2004 | WO2003091399A3 Production and use of salt tolerant and culture density tolerant organisms |
| 08/26/2004 | WO2003088905A3 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003060062A3 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2003052055A3 Egvii endoglucanase and nucleic acids encoding the same |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2002030268A3 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 08/26/2004 | US20040168212 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 08/26/2004 | US20040168211 Regulation of quinolate phosphoribosyl transferase expression |
| 08/26/2004 | US20040167634 Prosthetic kidney and its use for treating kidney disease |
| 08/26/2004 | US20040167319 Human monoclonal antibodies against CD20 |
| 08/26/2004 | US20040167091 Methods for treating ocular neovascular diseases |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |
| 08/26/2004 | US20040167061 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 08/26/2004 | US20040166579 Cell culture media for mammalian cells |
| 08/26/2004 | US20040166578 can improve the quality of the resulting blastocyst and can raise the ratio of the development into fetus and infant after transfer; genetic engineering |
| 08/26/2004 | US20040166565 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 08/26/2004 | US20040166562 has a reduced doubling time; for the production, expression and recovery of harvestable polypeptides, drug screening for metabolic activity, studying enteric disease and for use in a bio-artificial liver device |
| 08/26/2004 | US20040166561 Novel intein and uses thereof |
| 08/26/2004 | US20040166559 Vectors for gene therapy |
| 08/26/2004 | US20040166545 for drug screening using newly designed vectors coding for marker proteins and transfected cells; for high throughput assays |
| 08/26/2004 | US20040166544 Antibodies to c-Met for the treatment of cancers |
| 08/26/2004 | US20040166528 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 08/26/2004 | US20040166527 Compositions and methods for the identification of lung tumor cells |
| 08/26/2004 | US20040166507 Comprises nucleotide sequences coding aspartyl protease for identifying modulators for treatment of nervous system disorders; enzyme inhibitors |
| 08/26/2004 | US20040166486 RNA three dimensional structure (pseudoknot) which stimulates/activates protein synthesis; enhancement of cell-free translation of heterologous polypeptides |
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166108 Antibodies specific for plasmacytoid dendritic cells |
| 08/26/2004 | US20040166105 Compositions and methods relating to breast specific genes and proteins |
| 08/26/2004 | US20040166100 Treatment for arthritis |
| 08/26/2004 | US20040166099 Molecules preferentially associated with effector T cells and methods of their use |
| 08/26/2004 | US20040166098 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 08/26/2004 | US20040166097 Therapy for bone disease or lung defect |
| 08/26/2004 | US20040166096 Therapy for bone disorders; stem cells differentiated to gene expression of chondrocytes in biocompatible liquid |
| 08/26/2004 | US20040166095 Graft versus host disease; administering lymphocytes ,hematopoietic stem cells |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | CA2516236A1 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | CA2516123A1 Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents |
| 08/26/2004 | CA2515651A1 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 08/26/2004 | CA2515594A1 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 08/26/2004 | CA2515469A1 Progenitor cells from wharton's jelly of human umbilical cord |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515192A1 Compositions for neuronal tissue regeneration |
| 08/26/2004 | CA2515108A1 Directed genetic modifications of human stem cells |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449919A1 Process for producing substance |